FDA-approved filter debuts in Revitalift
This article was originally published in The Rose Sheet
Executive Summary
L'Oréal's newly launching Revitalift UV Daily Moisturizing Cream with Mexoryl SX is the first item in the U.S. containing Mexoryl SX (ecamsule), a moisturizer that protects against short- and long-wave UVA radiation and has just been approved by FDA, the company announces Oct. 15. The filter has been used in Europe for 13 years; the item offers UVA protection as well as SPF 15 (UVB) coverage, according to L'Oréal, which pegs UVA radiation as the primary cause of skin aging and a major contributor to the development of skin cancer. The cream is available at drug and mass doors...
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.